Prothix Overview
- Year Founded
-
2008

- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Prothix General Information
Description
Developer of bio-pharmaceutical products intended to give protein therapeutics for inflammatory and coagulation disorders. The company's bio-pharmaceuticals are monoclonal antibody products that include humanization and de-immunization of human cells sensitized with anti-human leukocyte antigen antibodies, enabling medical professionals to monitor and treat thromboembolic, inflammatory, and coagulation disorders.
Contact Information
Website
www.prothix.comCorporate Office
- Warmonderweg 23
- 2334 AB Leiden
- Netherlands
Corporate Office
- Warmonderweg 23
- 2334 AB Leiden
- Netherlands
Prothix Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Out of Business | 24-Mar-2023 | Completed | Out of Business | |||
2. Early Stage VC | 15-Aug-2011 | Completed | Generating Revenue | |||
1. University Spin-Out | 01-Jan-2008 | Completed | Startup |
Prothix Patents
Prothix Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20190106509-A1 | Monoclonal antibodies against the active site of factor xi and uses thereof | Active | 23-Mar-2016 | ||
US-11059905-B2 | Monoclonal antibodies against the active site of factor xi and uses thereof | Active | 23-Mar-2016 | ||
JP-7028471-B2 | Monoclonal antibody against the active site of factor xi and its use | Active | 23-Mar-2016 | ||
EP-3433279-A1 | Monoclonal antibodies against the active site of factor xi and uses thereof | Pending | 23-Mar-2016 | ||
JP-2019516395-A | Monoclonal antibodies against the active site of factor xi and their use | Active | 23-Mar-2016 | C07K16/36 |
Prothix Investments (1)
Prothix’s most recent deal was a Joint Venture with Broteio.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Broteio | Joint Venture | Drug Discovery |
Prothix FAQs
-
When was Prothix founded?
Prothix was founded in 2008.
-
Where is Prothix headquartered?
Prothix is headquartered in Leiden, Netherlands.
-
What industry is Prothix in?
Prothix’s primary industry is Drug Discovery.
-
Is Prothix a private or public company?
Prothix is a Private company.
-
What is Prothix’s current revenue?
The current revenue for Prothix is
. -
How much funding has Prothix raised over time?
Prothix has raised $942K.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »